Table 1.
Feature | Cases | miR‐552 expression | P‐value | |
---|---|---|---|---|
Low (n = 35) | High (n = 46) | |||
Sex | ||||
Male | 68 | 30 | 38 | |
Female | 13 | 5 | 8 | 0.706 |
Age | ||||
>50 | 45 | 20 | 25 | |
≤50 | 36 | 15 | 21 | 0.802 |
AFT(ng/mL) | ||||
>400 | 39 | 16 | 23 | |
≤400 | 42 | 20 | 22 | 0.551 |
Tumor size(cm) | ||||
>5 | 51 | 19 | 32 | |
≤5 | 30 | 16 | 14 | 0.158 |
Tumor number | ||||
Single | 41 | 17 | 24 | |
Multiple | 40 | 18 | 22 | 0.748 |
Histological grade | ||||
G1 | 25 | 18 | 7 | |
G2 + G3 | 56 | 17 | 39 | 0.001** |
TNM stage | ||||
I + II | 50 | 26 | 24 | |
III + IV | 31 | 9 | 22 | 0.043* |
Correlation between clinicopathological characteristics and miR‐552 expression was detected by chi‐square test. P < 0.05 was considered as significant. *indicated that P < 0.05 compared to I + II TNM stage, **indicated that P < 0.01 compared to G1 grade tumor.